Albright’s Hereditary Osteodystrophy

Search Trials
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Resistance to Vitamin D or Parathyroid Hormone
Status:
Recruiting
Last Changed:
Aug 6, 2019
First Changed:
Nov 4, 1999
Disease(s):
Hypocalcemia
Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
Status:
Unknown status
Last Changed:
Jul 6, 2007
First Changed:
Jul 6, 2007
Disease(s):
Pseudohypoparathyroidism
Intervention(s):
recombinant human somatotropin
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
Status:
Recruiting
Last Changed:
Aug 2, 2021
First Changed:
Sep 21, 2005
Disease(s):
Pseudohypoparathyroidism Type 1A
Intervention(s):
neurocognitive and psychosocial testing
Effect of Theophylline in Pseudohypoparathyroidism
Status:
Not yet recruiting
Last Changed:
Oct 24, 2018
First Changed:
Oct 24, 2018
Disease(s):
PHP Ia
Intervention(s):
Theophylline

Connect. Empower. Inspire.